The N-Methyl-D-Aspartate receptor (NMDAR) antagonist kynurenic acid (KYNA) and the post-synaptic calmodulin binding protein neurogranin (Nrgn) have been implicated in neurological and neuropsychiatric conditions including Alzheimer's disease and schizophrenia. This study indicates that systemic dual-lipopolysaccharide (LPS) injections increases KYNA in the medial prefrontal cortex (mPFC), which is accompanied with increased phosphorylation of nuclear factor kappa chain of activated B cells (NFκB) and activation of the nuclear factor of activated T-cells (NFAT). Our results also indicate that dual-LPS increases Nrgn phosphorylation and concomitantly reduces phosphorylation of calmodulin kinase-II (CaMKII). We confirmed that systemic blockade of kynurenine-3 monooxygenase in conjunction with kynurenine administration results in significant increases in Nrgn phosphorylation and a significant reduction of CaMKII phosphorylation in the mPFC. Consequently, dual-LPS administration induced significant impairments in stimulus processing during Pavlovian conditioning. Taken together, our study indicates that elevations in KYNA in the mPFC can directly regulate NMDA-NrgnCaMKII signaling, suggesting that neuroinflammatory conditions affecting this pathway may be associated with cognitive dysfunction.
A B S T R A C T
The N-Methyl-D-Aspartate receptor (NMDAR) antagonist kynurenic acid (KYNA) and the post-synaptic calmodulin binding protein neurogranin (Nrgn) have been implicated in neurological and neuropsychiatric conditions including Alzheimer's disease and schizophrenia. This study indicates that systemic dual-lipopolysaccharide (LPS) injections increases KYNA in the medial prefrontal cortex (mPFC), which is accompanied with increased phosphorylation of nuclear factor kappa chain of activated B cells (NFκB) and activation of the nuclear factor of activated T-cells (NFAT). Our results also indicate that dual-LPS increases Nrgn phosphorylation and concomitantly reduces phosphorylation of calmodulin kinase-II (CaMKII). We confirmed that systemic blockade of kynurenine-3 monooxygenase in conjunction with kynurenine administration results in significant increases in Nrgn phosphorylation and a significant reduction of CaMKII phosphorylation in the mPFC. Consequently, dual-LPS administration induced significant impairments in stimulus processing during Pavlovian conditioning. Taken together, our study indicates that elevations in KYNA in the mPFC can directly regulate NMDA-NrgnCaMKII signaling, suggesting that neuroinflammatory conditions affecting this pathway may be associated with cognitive dysfunction.
Introduction
Although the molecular underpinnings of neuropsychiatric pathophysiology remain elusive, recent studies have implicated pro-inflammatory cytokines in schizophrenia (SCZ), bipolar disorder, and depression (Beumer et al., 2012; Khandaker and Dantzer, 2016; Soderlund et al., 2011 Soderlund et al., , 2009 . In microglia and astrocytes, pro-inflammatory cytokines induce indoleamine 2, 3 dioxygenase (IDO-1) and tryptophan 2, 3 dioxygenase (TDO2), thus stimulating tryptophan degradation along the kynurenine pathway (Campbell et al., 2014; Sellgren et al., 2015) . Activation of this pathway increases formation of kynurenic acid (KYNA), a terminal metabolite shown to be elevated in the cerebrospinal fluid (CSF) and post mortem brain of patients with bipolar disorder and schizophrenia (Erhardt et al., 2001; Schwarcz et al., 2001; Sellgren et al., 2015) . Interestingly, the kynurenine pathway also produces the excitotoxic N-Methyl-D-Aspartate receptor (NMDAR) agonist quinolinic acid (QUIN), which has been shown to be elevated in the CSF of suicide attempters (Brundin et al., 2016; Erhardt et al., 2013; Lugo-Huitron et al., 2013) . KYNA blocks the glycine site of the NMDAR as well as the cholinergic α7 nicotinic receptor (Hilmas et al., 2001; Schwarcz et al., 2012) . Investigation of NMDAR dependent signaling has recently identified associations between patients with SCZ and risk variants on the neurogranin (Nrgn) gene, which codes for a calmodulin binding protein functionally situated upstream of calcineurin and downstream of the NMDAR (Broadbelt et al., 2006; Ruano et al., 2008; Thong et al., 2013) . Additional studies have shown that Nrgn variants are clinically associated with deficits in hippocampal activity during contextual learning (Pohlack et al., 2011) , while constitutive deletion of this gene in mice indicate that it is necessary for hippocampal spatial memory function (Huang et al., 2006; Pak et al., 2000) . However, the role of Nrgn in neuropsychiatric conditions remains unclear, as this protein has been proposed to be a 
